Advisory Alpha’s Exact Sciences EXAS Stock Holding History

Advisory Alpha’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,699	Closed	-$208K	–	530
2025 Q3	$208K	Buy	+3,699	New	+$185K	0.01%	499
2025 Q1	–	Sell	-3,737	Closed	-$210K	–	462
2024 Q4	$210K	Hold	3,737	–	–	0.01%	417
2024 Q3	$255K	Buy	+3,737	New	+$211K	0.01%	353
2024 Q2	–	Sell	-3,699	Closed	-$255K	–	404
2024 Q1	$255K	Hold	3,699	–	–	0.01%	331
2023 Q4	$274K	Hold	3,699	–	–	0.01%	278
2023 Q3	$252K	Buy	3,699 +31	+0.8%	+$2.63K	0.01%	260
2023 Q2	$344K	Hold	3,668	–	–	0.02%	245
2023 Q1	$249K	Buy	+3,668	New	+$236K	0.02%	246
2022 Q2	–	Sell	-3,516	Closed	-$246K	–	255
2022 Q1	$246K	Hold	3,516	–	–	0.02%	237
2021 Q4	$274K	Hold	3,516	–	–	0.02%	224
2021 Q3	$336K	Buy	+3,516	New	+$371K	0.02%	193
2020 Q1	–	Sell	-1,300	Closed	-$117K	–	751
2019 Q4	$117K	Buy	+1,300	New	+$114K	0.03%	189

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Advisory Alpha's EXAS Position: Q4 2025 in Review

Advisory Alpha sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 3,699 shares — an estimated $208K sold.

Advisory Alpha first reported a position in EXAS in Q4 2019 and held it in 12 quarters. The position peaked at $344K in Q2 2023. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

Advisory Alpha reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
Advisory Alpha sold 3,699 Exact Sciences shares in Q4 2025, an estimated $208K.
Advisory Alpha first reported a position in Exact Sciences in Q4 2019 and held it in 12 quarters.
Advisory Alpha's Exact Sciences position peaked at $344K in Q2 2023.
711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Advisory Alpha's 13F filing for Q4 2025, filed 6 Feb 2026.